Results 151 to 160 of about 3,147 (209)
An approach to treat refractory catheter-related infections in patients undergoing peritoneal dialysis: tunnel-reconstruction operation. [PDF]
Tian J +11 more
europepmc +1 more source
Antibiotic fosmidomycin protects bacteria from cell wall perturbations by antagonizing oxidative damage-mediated cell lysis. [PDF]
Kawai Y, Errington J.
europepmc +1 more source
Structural and functional studies of mycobacterial IspD enzymes
A number of pathogens, including the causative agents of tuberculosis and malaria, synthesize isopentenyl diphosphate via the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway rather than the classical mevalonate pathway found in humans.
Sherry L Mowbray +2 more
exaly +7 more sources
Tuberculosis is a serious threat to world-wide public health usually caused in humans by Mycobacterium tuberculosis (M. tuberculosis). It exclusively utilizes the methylerythritol phosphate (MEP) pathway for biosynthesis of isopentenyl diphosphate (IPP ...
Peng Gao, Jianzhou Meng, Chunling Xiao
exaly +2 more sources
ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment [PDF]
Abstract Peritonitis is a common and serious complication of peritoneal dialysis (PD). Although less than 5% of peritonitis episodes result in death, peritonitis is the direct or major contributing cause of death in around 16% of PD patients (1-6).
Beth Piraino, David Johnson, Eric Goffin
exaly +8 more sources
Structure based de novo design of IspD inhibitors as anti-tubercular agents [PDF]
Tuberculosis is one of the leading contagious diseases, caused by Mycobacterium tuberculosis. Despite improvements in anti-tubercular agents, it remains one of the most prevalent infectious diseases worldwide, responsible for a total of 1.6 million ...
Venkata Krishnan Ramaswamy
exaly +2 more sources

